Requirements for Brazilian Outpatient Centers of Excellence in Hidradenitis Suppurativa: Consensus Co-Creative Study

Background Hidradenitis suppurativa (HS) is a chronic skin condition. Its complexity and impact on patients highlight the need for multidisciplinary care that can address the physical, psychological, and social aspects. Centers of excellence can ideally provide the necessary infrastructure, resources, and expertise to effectively treat HS. However, there are still no consolidated models of centers of excellence in HS, and establishing their foundations is an intricate research challenge. Purposely, design and co-creation as innovation techniques are helpful approaches to this type of research. Methods In this study, we conducted a co-creation with consensus among HS specialists to propose the criteria and requirements to establish outpatient centers of excellence of HS in Brazil. We followed a linear process with mixed methods in 6 stages. Results The process resulted in 10 categories for establishing outpatient centers, including their respective requirements, rationale, and classification. The categories include onboarding and welcoming; infrastructure and procedures; infusion therapy; flows and referrals; staffing; disease management; metrics during diagnosis; metrics during treatment; awareness and advocacy; research and education. Discussion The idealized outpatient centers can play a role in the complete multidisciplinary treatment for HS and advancing the science of healthcare services by providing a focus for research, training, and translation of findings into practice.

[1]  V. Shi,et al.  A practical guide to starting a hidradenitis suppurativa specialty clinic , 2023, JAAD International.

[2]  V. Shi,et al.  Optimizing hidradenitis suppurativa clinic visits: Patient perspectives , 2022, International Journal of Women's Dermatology.

[3]  S. Allender,et al.  Co-creation, co-design, co-production for public health - a perspective on definition and distinctions. , 2022, Public health research & practice.

[4]  C. Zouboulis,et al.  New treatments and new assessment instruments for Hidradenitis suppurativa , 2022, Experimental dermatology.

[5]  A. Fekadu,et al.  Conceptualising centres of excellence: a scoping review of global evidence , 2022, BMJ Open.

[6]  G. Fabbrocini,et al.  Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review , 2022, Biomedicines.

[7]  S. Lee,et al.  A visit guide for adolescent hidradenitis suppurativa: Bridging the divide between pediatric and adult care , 2022, JAAD International.

[8]  J. Szepietowski,et al.  Indirect Self-Destructiveness in Hidradenitis Suppurativa Patients , 2021, Journal of Clinical Medicine.

[9]  F. Sampogna,et al.  Pain as Defining Feature of Health Status and Prominent Therapeutic Target in Patients with Hidradenitis Suppurativa , 2021, Journal of clinical medicine.

[10]  G. Fabbrocini,et al.  Hidradenitis Suppurativa: Where We Are and Where We Are Going , 2021, Cells.

[11]  E. Țarcă,et al.  Multidisciplinary Management of Adolescents with Hidradenitis Suppurativa – Series of Cases and Literature Review , 2021, Journal of multidisciplinary healthcare.

[12]  T. Montero-Vílchez,et al.  The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis , 2021, International journal of environmental research and public health.

[13]  A. Finlay,et al.  Quality of Life in Hidradenitis Suppurativa: An Update , 2021, International journal of environmental research and public health.

[14]  M. Gilmour,et al.  A generative co-design framework for healthcare innovation: development and application of an end-user engagement framework , 2021, Research Involvement and Engagement.

[15]  Ericles Andrei Bellei,et al.  A Bowling Exergame to Improve Functional Capacity in Older Adults: Co-Design, Development, and Testing to Compare the Progress of Playing Alone Versus Playing With Peers , 2021, JMIR serious games.

[16]  A. Beurskens,et al.  How to support a co-creative research approach in order to foster impact. The development of a Co-creation Impact Compass for healthcare researchers , 2020, PloS one.

[17]  Francesco Schiavone,et al.  Re-designing the service experience in the value co-creation process: an exploratory study of a healthcare network , 2020, Bus. Process. Manag. J..

[18]  Sven M. Laudien,et al.  Co-creation in coworking-spaces: boundary conditions of diversity , 2020 .

[19]  Habibolah Khazaie,et al.  A Mixed-Method Modified Delphi Study toward Identifying Key Elements of Psychotherapy in Iran , 2020, International journal of environmental research and public health.

[20]  Alexander K. Saeri,et al.  Research co-design in health: a rapid overview of reviews , 2020, Health Research Policy and Systems.

[21]  A. Gottlieb,et al.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. , 2019, Journal of the American Academy of Dermatology.

[22]  A. Gottlieb,et al.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. , 2019, Journal of the American Academy of Dermatology.

[23]  G. Duarte,et al.  Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology* , 2019, Anais brasileiros de dermatologia.

[24]  Yevgeniy Feyman,et al.  Association between patient outcomes and accreditation in US hospitals: observational study , 2018, British Medical Journal.

[25]  Tanya Marchant,et al.  High-quality health systems in the Sustainable Development Goals era: time for a revolution , 2018, The Lancet. Global health.

[26]  A. Gottlieb,et al.  A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process , 2018, The British journal of dermatology.

[27]  G. W. Campos Future prospects for the SUS. , 2018, Ciencia & saude coletiva.

[28]  Sheila Leatherman,et al.  Delivering Quality Health Services: A Global Imperative for Universal Health Coverage , 2018 .

[29]  H. Miot,et al.  Prevalence of hidradenitis suppurativa in Brazil: a population survey , 2018, International journal of dermatology.

[30]  Pedro Paulo Balestrassi,et al.  The Influence of Accreditation on the Sustainability of Organizations with the Brazilian Accreditation Methodology , 2018, Journal of healthcare engineering.

[31]  J. Fortenberry,et al.  Centers of excellence in healthcare institutions: what they are and how to assemble them , 2017, BMC Health Services Research.

[32]  R. Jandarov,et al.  Factors Contributing to Depression and Chronic Pain in Patients with Hidradenitis Suppurativa: Results from a Single-Center Retrospective Review , 2017, Dermatology.

[33]  J. Bousquet,et al.  Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.

[34]  Tina Janamian,et al.  Achieving Research Impact Through Co‐creation in Community‐Based Health Services: Literature Review and Case Study , 2016, The Milbank quarterly.

[35]  J. Lapins,et al.  European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[36]  S. Halevy,et al.  Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[37]  A. Mehrotra,et al.  Ensuring excellence in centers of excellence programs. , 2015, Annals of surgery.

[38]  D. Gheonea,et al.  Excellence centers in inflammatory bowel disease in Romania: a measure of the quality of care. , 2014, Journal of gastrointestinal and liver diseases : JGLD.

[39]  Kathleen M. MacQueen,et al.  Applied Thematic Analysis , 2011 .

[40]  M. Angastiniotis,et al.  Requirements for a Reference or Expert Thalassemia Center: The Structure/model for Centers Dealing with Chronic/hereditary Blood Disorders , 2009, Hemoglobin.

[41]  H. Kurzen,et al.  What causes hidradenitis suppurativa? , 2008, Experimental dermatology.

[42]  Jeffrey Braithwaite,et al.  Health sector accreditation research: a systematic review. , 2008, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[43]  N. Arora,et al.  Focus group discussions in medical research , 2000, Indian journal of pediatrics.

[44]  Human-Centered Service Design for Healthcare Transformation: Development, Innovation, Change , 2023 .

[45]  G. Jemec,et al.  Increased Suicide Risk in Patients with Hidradenitis Suppurativa. , 2018, The Journal of investigative dermatology.